Global Markets React to Nikkei Dip, Instacart Under FTC Scrutiny, and GOP Health Bill Passage
Key Takeaways Japan's Nikkei 225 futures experienced a notable decline of 1.29% in early trade, reflecting broader weakness across Asian […]
Energy Markets Surge on LNG Demand, Geopolitical Talks Eye Ukraine Peace
Key Takeaways U.S. natural gas futures surged by 5% in post-settlement trade, driven by near-record liquefied natural gas (LNG) export
Cinven’s CEO and CFO Step Down Amidst UK Price Gouging Ban Risk
Key Takeaways Cinven's CEO and CFO/COO are reportedly stepping down from their positions following reports that the UK's Competition and
[EconCal]Economic Calendar: Key Events Driving Market Volatility
Upcoming high-impact events include Thursday's 8:30 AM EST CPI data, crucial for inflation outlook. Next Monday, GDP Annualized at 8:30
Cautious Optimism Prevails: Futures Point Higher Amid Economic Data and Geopolitical Tensions
U.S. stock futures are pointing to a cautiously optimistic start to Wednesday's trading session, December 17, 2025, as investors digest
Market Movers: WBD Backs Netflix, FED Sees 4.2% Price Hike, General Mills Beats Estimates
Key Takeaways Warner Bros. Discovery (WBD) has unanimously recommended shareholders reject Paramount Skydance's (PSKY) offer, instead endorsing a merger with
[DowJonesToday]Dow Jones Navigates Economic Data Anticipation and AI Sector Concerns
The Dow Jones Industrial Average (^DJI) was down 41.49 points, a -0.0856% change, with the index standing at 48416.56 today,
Market Jitters as Futures Slip Ahead of Crucial Jobs Data; AI Stocks Under Pressure
U.S. stock futures are signaling a cautious start to Tuesday's trading session, December 16, 2025, as investors brace for a
UK Gilt Yields Surge as Strong Flash PMI Data Fuels Economic Optimism
Key Takeaways UK 5-year gilt yields climbed to 3.984%, an increase of 3 basis points, reaching their highest level since
Major Policy Shifts from Trump Administration, GSK Drug Approval, and Geopolitical Tensions Dominate Monday’s Headlines
Key Takeaways GSK (GSK) secured UK approval for Exdensur (depemokimab), a groundbreaking twice-yearly biological medicine for asthma and chronic rhinosinusitis,